Oireachtas Joint and Select Committees

Wednesday, 12 July 2017

Joint Oireachtas Committee on Health

Evaluating Orphan Drugs: Discussion

9:00 am

Photo of Colm BurkeColm Burke (Fine Gael)
Link to this: Individually | In context | Oireachtas source

My problem is that per head of population, we are paying far more than an awful lot of other EU jurisdictions. When one goes back to the German situation, the Germans are not paying out the price the pharmaceutical companies are asking for because they can strike a very good bargain because they are dealing with a bigger population. We seem to be coming out of the wrong end when we are negotiating for orphan drugs because we have far fewer numbers who can benefit from the medication so the drug companies are very much in the driving seat. It is a huge problem. It is a case of trying to find a solution.